HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS.

Abstract
Modulation of tumour oxygenation may be used to increase or decrease tumour hypoxia in order to improve the effect of radiotherapy or bioreductive drugs, respectively. Magnetic resonance imaging (MRI) and near infrared spectroscopy (NIRS) are techniques sensitive to blood deoxyhemoglobin concentration (Hb) that can be used to investigate tumour hypoxia indirectly via blood oxygenation levels. In this study we have used NIRS to determine absolute Hb and changes in deoxyhemoglobin and oxyhemoglobin (HbO) in subcutaneous rodent tumours for challenges that alter blood flow and oxygenation, with the aim to better interpret our MRI data. Both carbogen [95% O2 + 5% CO2] and 100% O2 breathing produced a similar and significant reduction in Hb and increase in HbO, but a negligible change in HbT (= Hb + HbO). In contrast, N2 breathing to terminal anoxia and intravenous hydralazine produced a negligible increase in Hb, but large reductions in HbO and HbT. HbT is proportional to blood volume, so our data suggests large blood volume decreases occur with challenges likely to cause reduced arterial blood pressure. Hence MRI techniques that measure the R2* relaxation rate, which varies linearly with total Hb, will underestimate the effects of hypotensive agents at increasing tumour hypoxia.
AuthorsFranklyn A Howe, James P Connelly, Simon P Robinson, Roger Springett, John R Griffiths
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 566 Pg. 75-81 ( 2005) ISSN: 0065-2598 [Print] United States
PMID16594137 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins
  • Oxyhemoglobins
  • Carbon Dioxide
  • Hydralazine
  • carbogen
  • deoxyhemoglobin
  • Oxygen
Topics
  • Animals
  • Carbon Dioxide (pharmacology)
  • Female
  • Hemoglobins (metabolism)
  • Hydralazine (pharmacology)
  • Hyperoxia (physiopathology)
  • Hypoxia (physiopathology)
  • Magnetic Resonance Imaging
  • Oxygen (blood, pharmacology)
  • Oxyhemoglobins (metabolism)
  • Pituitary Neoplasms (blood, blood supply, drug therapy, radiotherapy)
  • Prolactinoma (blood, blood supply, drug therapy, radiotherapy)
  • Radiation Tolerance
  • Rats
  • Rats, Inbred WF
  • Regional Blood Flow
  • Spectroscopy, Near-Infrared

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: